Abstract
Background: Enhanced external counterpulsation (EECP) is a noninvasive, outpatient treatment designed to increase myocardial perfusion pressure and decrease cardiac workload. EECP has been demonstrated to be safe, well tolerated and effective for the relief of angina in patients with left ventricular dysfunction (LVD). We examined the therapeutic efficacy of EECP on patient functional status and quality of life as assessed by the Duke Activity Status Index (DASI), a standardized assessment of functional status that correlates well with peak oxygen uptake (Spearman correlation coefficient, 0.58).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
